Rainer von Coelln - Concepedia

Author

Rainer von Coelln

Also Known As

Emily Young, Lisa M. Shulman, R von Coelln, R. Von Coelln, R. von Coelln, R.V. Coelln, Rainer Coelln, Rainer V. Coelln, Rainer Von Coelln, Rainer von Coelln

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

University of Maryland, Baltimore University of Tübingen Baylor College of Medicine Neurological Research Institute Texas Children's Hospital

About

Rainer von Coelln is an author at University of Maryland, Baltimore specializing in medicine, neurology, and neuroscience.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.5K
2	Health Sciences	3	3	137
3	Public Health	3	3	164
4	Social Sciences	3	3	446
5	Natural Sciences	1	1	245

Rainer von Coelln

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
Parkinson's disease age at onset genome‐wide association study: Defining heritability, genetic loci, and α‐synuclein mechanisms Cornelis Blauwendraat, Karl Heilbron, Costanza L. Vallerga, Movement Disorders	2019	365
Loss of locus coeruleus neurons and reduced startle in parkin null mice Rainer von Coelln, Bobby Thomas, Joseph M. Savitt, Proceedings of the National Academy of Sciences GeneticsNeurotransmissionCellular NeurobiologySynaptic SignalingSocial Sciences	2004	344
Accumulation of the Authentic Parkin Substrate Aminoacyl-tRNA Synthetase Cofactor, p38/JTV-1, Leads to Catecholaminergic Cell Death Han Seok Ko, Rainer von Coelln, Sathya R. Sriram, Journal of Neuroscience MitophagyCatecholaminergic Cell DeathMolecular BiologyCell DeathProtein Synthesis	2005	245
Protection by Synergistic Effects of Adenovirus-Mediated X-Chromosome-Linked Inhibitor of Apoptosis and Glial Cell Line-Derived Neurotrophic Factor Gene Transfer in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease O. Eberhardt, Rainer von Coelln, Sebastian Kügler, Journal of Neuroscience Adenovirus-mediated X-chromosome-linked InhibitorMedicineExperimental NeuropathologyDopaminergic Snpc NeuronsCell Death	2000	208
Expanding Parkinson’s disease genetics: novel risk loci, genomic context, causal insights and heritable risk Mike A. Nalls, Cornelis Blauwendraat, Costanza L. Vallerga, GeneticsGenetic EpidemiologyBrain VolumesGenome-wide Association StudiesGenome-wide Association Study	2018	125
Rescue from death but not from functional impairment: caspase inhibition protects dopaminergic cells against 6-hydroxydopamine-induced apoptosis but not against the loss of their terminals Rainer von Coelln, Sebastian Kügler, Mathias Bähr, Journal of Neurochemistry MitophagyApoptosis ProteinMedicineApoptosisAutophagy	2001	96
Extended therapeutic window for caspase inhibition and synergy with MK-801 in the treatment of cerebral histotoxic hypoxia Jörg B. Schulz, Michael Weller, Russell T. Matthews, Cell Death and Differentiation Cerebral Vascular RegulationMedicineHypoxia (Medicine)Caspase InhibitionCell Death	1998	95
Ultrasound‐guided injection of the iliopsoas muscle with botulinum toxin in camptocormia Rainer von Coelln, Armin Raible, Thomas Gasser, Movement Disorders KinesiologyMedicineIliopsoas MusclePhysiologyBotulinum Toxin	2008	85
Inclusion Body Formation and Neurodegeneration Are Parkin Independent in a Mouse Model of α-Synucleinopathy Rainer von Coelln, Bobby Thomas, Shaida A. Andrabi, Journal of Neuroscience	2006	82
MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity Bobby Thomas, Rainer von Coelln, Allen S. Mandir, Neurobiology of Disease Substantia NigraNeurophysiologyMedicineSynaptic TransmissionPhysiology	2007	69

Page 1